Boston Scientific Corporation (0HOY.L)
USD 87.04
(-4.32%)
USD 87.04
(-4.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 15.6 Billion USD | 4.77% |
| 2022 | 14.89 Billion USD | -4.56% |
| 2021 | 15.6 Billion USD | 1.02% |
| 2020 | 15.45 Billion USD | -7.42% |
| 2019 | 16.68 Billion USD | 35.97% |
| 2018 | 12.27 Billion USD | 2.02% |
| 2017 | 12.03 Billion USD | 5.87% |
| 2016 | 11.36 Billion USD | -3.81% |
| 2015 | 11.81 Billion USD | 11.79% |
| 2014 | 10.56 Billion USD | 5.33% |
| 2013 | 10.03 Billion USD | -2.45% |
| 2012 | 10.28 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 16.5 Billion USD | 5.73% |
| 2024 Q2 | 16.49 Billion USD | -0.01% |
| 2024 Q3 | 17.12 Billion USD | 3.78% |
| 2023 FY | 15.6 Billion USD | 4.77% |
| 2023 Q4 | 15.6 Billion USD | 4.64% |
| 2023 Q2 | 15.11 Billion USD | 2.25% |
| 2023 Q3 | 14.91 Billion USD | -1.34% |
| 2023 Q1 | 14.78 Billion USD | -0.76% |
| 2022 Q4 | 14.89 Billion USD | 4.12% |
| 2022 Q2 | 14.93 Billion USD | -4.26% |
| 2022 Q1 | 15.6 Billion USD | -0.03% |
| 2022 FY | 14.89 Billion USD | -4.56% |
| 2022 Q3 | 14.3 Billion USD | -4.23% |
| 2021 Q2 | 15.22 Billion USD | 0.29% |
| 2021 Q4 | 15.6 Billion USD | 1.23% |
| 2021 FY | 15.6 Billion USD | 1.02% |
| 2021 Q3 | 15.41 Billion USD | 1.26% |
| 2021 Q1 | 15.18 Billion USD | -1.75% |
| 2020 FY | 15.45 Billion USD | -7.42% |
| 2020 Q1 | 16.3 Billion USD | -2.27% |
| 2020 Q2 | 15.2 Billion USD | -6.76% |
| 2020 Q4 | 15.45 Billion USD | 1.11% |
| 2020 Q3 | 15.28 Billion USD | 0.49% |
| 2019 Q3 | 17.05 Billion USD | 14.6% |
| 2019 Q2 | 14.88 Billion USD | 2.16% |
| 2019 FY | 16.68 Billion USD | 35.97% |
| 2019 Q1 | 14.56 Billion USD | 18.71% |
| 2019 Q4 | 16.68 Billion USD | -2.16% |
| 2018 Q2 | 11.87 Billion USD | -2.47% |
| 2018 Q1 | 12.17 Billion USD | 1.18% |
| 2018 FY | 12.27 Billion USD | 2.02% |
| 2018 Q4 | 12.27 Billion USD | 1.51% |
| 2018 Q3 | 12.09 Billion USD | 1.84% |
| 2017 Q4 | 12.03 Billion USD | 8.89% |
| 2017 FY | 12.03 Billion USD | 5.87% |
| 2017 Q2 | 11.14 Billion USD | 2.36% |
| 2017 Q1 | 10.89 Billion USD | -4.16% |
| 2017 Q3 | 11.04 Billion USD | -0.89% |
| 2016 Q1 | 11.26 Billion USD | -4.67% |
| 2016 Q4 | 11.36 Billion USD | 1.32% |
| 2016 Q3 | 11.21 Billion USD | -3.47% |
| 2016 Q2 | 11.61 Billion USD | 3.17% |
| 2016 FY | 11.36 Billion USD | -3.81% |
| 2015 Q2 | 10.54 Billion USD | 5.74% |
| 2015 FY | 11.81 Billion USD | 11.79% |
| 2015 Q4 | 11.81 Billion USD | 0.07% |
| 2015 Q3 | 11.8 Billion USD | 11.97% |
| 2015 Q1 | 9.97 Billion USD | -5.64% |
| 2014 Q2 | 9.93 Billion USD | 1.35% |
| 2014 Q3 | 10.01 Billion USD | 0.85% |
| 2014 Q4 | 10.56 Billion USD | 5.49% |
| 2014 FY | 10.56 Billion USD | 5.33% |
| 2014 Q1 | 9.8 Billion USD | -2.3% |
| 2013 Q2 | 10.39 Billion USD | 1.3% |
| 2013 Q1 | 10.26 Billion USD | -0.23% |
| 2013 FY | 10.03 Billion USD | -2.45% |
| 2013 Q3 | 10.35 Billion USD | -0.38% |
| 2013 Q4 | 10.03 Billion USD | -3.11% |
| 2012 Q4 | 10.28 Billion USD | 0.0% |
| 2012 FY | 10.28 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -12944.569% |
| Accuray Incorporated | 423.54 Million USD | -3584.632% |
| Align Technology, Inc. | 2.45 Billion USD | -536.1% |
| Elevance Health Inc. | 69.52 Billion USD | 77.553% |
| AxoGen, Inc. | 101.16 Million USD | -15326.741% |
| CVS Health Corporation | 173.09 Billion USD | 90.984% |
| Cardinal Health, Inc. | 48.33 Billion USD | 67.712% |
| Centene Corporation | 58.68 Billion USD | 73.407% |
| DaVita Inc. | 14.87 Billion USD | -4.906% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 71.703% |
| Hologic, Inc. | 4.02 Billion USD | -287.63% |
| Humana Inc. | 30.74 Billion USD | 49.244% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -779.016% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -76.646% |
| Masimo Corporation | 1.67 Billion USD | -830.757% |
| McKesson Corporation | 69.04 Billion USD | 77.396% |
| Patterson Companies, Inc. | 1.89 Billion USD | -723.536% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -105.234% |
| ResMed Inc. | 2 Billion USD | -677.055% |
| Henry Schein, Inc. | 5.42 Billion USD | -187.934% |
| Teladoc Health, Inc. | 2.06 Billion USD | -655.264% |
| Universal Health Services, Inc. | 8.15 Billion USD | -91.369% |
| Veeva Systems Inc. | 1.26 Billion USD | -1132.608% |
| Baxter International Inc. | 19.8 Billion USD | 21.214% |
| Becton, Dickinson and Company | 26.98 Billion USD | 42.166% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -663.428% |
| Danaher Corporation | 30.99 Billion USD | 49.655% |
| Stryker Corporation | 21.31 Billion USD | 26.798% |
| Medtronic plc | 39.56 Billion USD | 60.552% |